Literature DB >> 17954263

Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.

Boutheina Hadhri-Guiga1, Nabil Toumi, Abdelmajid Khabir, Tahia Sellami-Boudawara, Abdelmoonem Ghorbel, Jamel Daoud, Mounir Frikha, Ali Gargouri, Raja Mokdad-Gargouri.   

Abstract

A common polymorphism at codon 72 of TP53, the gene encoding the tumor suppressor protein p53, encodes either arginine or proline. These variants may be associated with tumor susceptibility since they interfere with the ability of TP53 to activate apoptosis, and might account for ethnic variation in cancer frequency. Using a polymerase chain reaction-restriction fragment length polymorphism assay, we tested peripheral blood samples from 115 patients with nasopharyngeal carcinoma (NPC) and from 83 healthy individuals. Patients with NPC (Arg/Arg = 38.26%, Arg/Pro = 41.73%, and Pro/Pro = 20%) showed a significantly different percentage of the Pro/Pro genotype, compared with the control population (Arg/Arg = 39%, Arg/Pro = 54%, and Pro/Pro = 7%) (P = 0.0307). No significant difference was observed between TP53 codon 72 polymorphism and age, sex, histological grade, and metastasis. These results provide evidence that individuals with the Pro/Pro genotype have an increased risk of developing NPC in Tunisia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17954263     DOI: 10.1016/j.cancergencyto.2007.05.013

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  11 in total

1.  Association between the P53 codon 72 polymorphism and nasopharyngeal cancer risk.

Authors:  Kemin Cai; Yu Wang; Xiaojun Zhao; Xueli Bao
Journal:  Tumour Biol       Date:  2013-10-11

2.  The association between gene polymorphisms and risk of nasopharyngeal carcinoma.

Authors:  Jiqiao Yang; Lu Li; Xueru Yin; Fanyi Wu; Jiani Shen; Yuanling Peng; Yuqi Liu; Yaling Sun; Hongwei Lu; Yonggang Zhang
Journal:  Med Oncol       Date:  2014-12-07       Impact factor: 3.064

3.  The p53 codon 72 Pro/Pro genotype identifies poor-prognosis neuroblastoma patients: correlation with reduced apoptosis and enhanced senescence by the p53-72P isoform.

Authors:  Sara Cattelani; Giovanna Ferrari-Amorotti; Sara Galavotti; Raffaella Defferrari; Barbara Tanno; Samantha Cialfi; Jenny Vergalli; Valentina Fragliasso; Clara Guerzoni; Gloria Manzotti; Angela Rachele Soliera; Chiara Menin; Roberta Bertorelle; Heather P McDowell; Alessandro Inserra; Maria Luisa Belli; Luigi Varesio; Deborah Tweddle; Gian Paolo Tonini; Pierluigi Altavista; Carlo Dominici; Giuseppe Raschellà; Bruno Calabretta
Journal:  Neoplasia       Date:  2012-07       Impact factor: 5.715

4.  Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma.

Authors:  Lijuan Li; Jian Wu; Xiutian Sima; Peng Bai; Wei Deng; Xueke Deng; Lin Zhang; Linbo Gao
Journal:  Tumour Biol       Date:  2013-03-17

5.  P53 gene polymorphisms and breast cancer risk in Arab women.

Authors:  Shafika Alawadi; Lina Ghabreau; Mervat Alsaleh; Zainab Abdulaziz; Mohamed Rafeek; Nizar Akil; Moussa Alkhalaf
Journal:  Med Oncol       Date:  2010-05-05       Impact factor: 3.064

6.  p53 Codon 72 arginine/proline polymorphism and cancer in Sudan.

Authors:  Huda A Eltahir; Ameera A M Adam; Zeinab A Yahia; Noon F Ali; Dalia M Mursi; Ashraaf M Higazi; Nahid A Eid; Ahmed M Elhassan; Hiba S Mohammed; Muntaser E Ibrahim
Journal:  Mol Biol Rep       Date:  2012-10-08       Impact factor: 2.316

Review 7.  Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.

Authors:  Giorgio Sirugo; Branwen J Hennig; Adebowale A Adeyemo; Alice Matimba; Melanie J Newport; Muntaser E Ibrahim; Kelli K Ryckman; Alessandra Tacconelli; Renato Mariani-Costantini; Giuseppe Novelli; Himla Soodyall; Charles N Rotimi; Raj S Ramesar; Sarah A Tishkoff; Scott M Williams
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132

8.  Association of p53 codon72 Arg>Pro polymorphism with susceptibility to nasopharyngeal carcinoma: evidence from a case-control study and meta-analysis.

Authors:  S K Sahu; S Chakrabarti; S D Roy; N Baishya; R R Reddy; S Suklabaidya; A Kumar; S Mohanty; S Maji; A Suryanwanshi; S Rajasubramaniam; M Asthana; A K Panda; S P Singh; S Ganguly; O P Shaw; A K Bichhwalia; P K Sahoo; N R Chattopadhyay; K Chatterjee; C N Kundu; A K Das; R Kannan; E Zomawia; S A Sema; Y I Singh; S K Ghosh; K Sharma; B S Das; T Choudhuri
Journal:  Oncogenesis       Date:  2016-05-09       Impact factor: 7.485

9.  TP53 codon 72 Gene Polymorphism Paradox in Associated with Various Carcinoma Incidences, Invasiveness and Chemotherapy Responses.

Authors:  Hung-Yu Lin; Chun-Hsiung Huang; Wen-Jen Wu; Li-Ching Chang; For-Wey Lung
Journal:  Int J Biomed Sci       Date:  2008-12

10.  Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population.

Authors:  Chao Yang; Xiang Ma; Dongxiao Liu; Younan Wang; Ran Tang; Yi Zhu; Zekuan Xu; Li Yang
Journal:  Tumour Biol       Date:  2014-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.